Jaguar Health (JAGX) 2025 Outlook for Investors and Analysts
Jaguar Health faces a pivotal year as its key drug Mytesi and pipeline shape 2025 outcomes. This guide breaks down Q3...
Curious about which travel cards have no annual fees? Find the best options to maximize your travel rewards.
26,862 articlesJaguar Health faces a pivotal year as its key drug Mytesi and pipeline shape 2025 outcomes. This guide breaks down Q3...
A Philadelphia primary delivers a surprise win for a self-described 'proud troublemaker' democratic socialist, beatin...
Thomas Siebel’s return as C3.AI CEO could reshape sales strategy and investor sentiment. This article breaks down wha...
Cisco stock has surged about 32% in the past 30 days as AI infrastructure demand climbs; Arista slid 10% and Broadcom...
A mega-cap AI stock has defied the hype by turning into the unexpected bargain of the Magnificent Seven. Learn what t...
Palantir faces a steeper path in 2026 as the stock retreats, yet bulls argue the core AI platform and government dema...
Microsoft’s stock has drifted lower this year even as its AI and cloud businesses show stronger momentum. This piece ...
A notable institutional purchase in Plains GP Holdings hints at a larger, value-driven view of the energy midstream s...
MicroStrategy offloads 32 BTC to cover dividend payouts on its perpetual preferred shares, signaling a shift from a p...
A 73-year-old retiree uses a QCD to convert a $60,000 RMD from a $1.6 million 401(k) into zero taxable income, a move...
Alphabet unveiled a record $84.75B equity sale to fuel AI infrastructure. The move sent ripples through the stock mar...
As Torrid approaches its 2026 earnings moment, investors seek signals on growth, margins, and the road to improved pr...